2:55 PM
 | 
Jan 12, 2018
 |  BC Extra  |  Politics & Policy

FDA delaying intended use regulation

FDA announced Friday that it is delaying the implementation of a proposed rule defining the “intended use” of medical products. The delay means that FDA is reconsidering language...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >